ETF Managers Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $355K | Sell |
432
-3,449
| -89% | -$2.83M | 0.01% | 519 |
|
|
2022
Q4 | $2.8M | Buy |
3,881
+3,587
| +1,220% | +$2.59M | 0.13% | 93 |
|
|
2022
Q3 | $203K | Buy |
294
+7
| +2% | +$4.83K | 0.01% | 596 |
|
|
2022
Q2 | $172K | Sell |
287
-98
| -25% | -$58.7K | 0.01% | 660 |
|
|
2022
Q1 | $267K | Sell |
385
-214
| -36% | -$148K | 0.01% | 558 |
|
|
2021
Q4 | $385K | Sell |
599
-145
| -19% | -$93.2K | 0.01% | 564 |
|
|
2021
Q3 | $451K | Buy |
744
+32
| +4% | +$19.4K | 0.01% | 547 |
|
|
2021
Q2 | $389K | Sell |
712
-94
| -12% | -$51.4K | 0.01% | 564 |
|
|
2021
Q1 | $379K | Buy |
806
+54
| +7% | +$25.4K | 0.01% | 552 |
|
|
2020
Q4 | $360K | Buy |
752
+121
| +19% | +$57.9K | 0.01% | 499 |
|
|
2020
Q3 | $362K | Buy |
631
+406
| +180% | +$233K | 0.01% | 383 |
|
|
2020
Q2 | $137K | Buy |
+225
| New | +$137K | ﹤0.01% | 572 |
|
|
2016
Q1 | $26K | Buy |
+66
| New | +$26K | 0.02% | 409 |
|